Yi-Xiang Wang, M.Med., Ph.D.

The Chinese University of Hong Kong, Hong Kong SAR.
Email: yixiang_wang@cuhk.edu.hk.

Dr. Yi-Xiang Wang read medicine, trained in diagnostic and interventional radiology, as well as obtained a research doctorate in China (PhD, Shanghai Med U). He did post-doctoral fellowships in Sheffield Medical School, UK, and Rotterdam School of Medicine (Erasmus MC), the Netherlands. Dr. Wang was with AstraZeneca Pharmaceuticals R&D (UK) as a senior scientist during 2001-2006. He joined the Faculty of Medicine at the Chinese University of Hong Kong in late 2006, where he is currently a professor. He is also an adjunct Professor of Jinan University, Guangzhou, China. Dr Wang is the Editor-in-Chief of Quant Imaging Med Surg journal. In recent years, his research has focused on three directions: (1) new techniques of liver magnetic resonance imaging; (2) degenerative diseases and osteoporotic fracture of the spine; (3) epidemiology of cerebral aneurysm rupture. He pioneered a number of liver MRI techniques such as T1rho, CEST, DDVD (diffusion derived vessel density), 3-dimenional analysis of IVIM parameters. His work on epidemiology of spine degeneration including disc space narrowing, spondylolisthesis, and osteoporotic fracture provides reference standard for East Asians, and also deepened the understanding of pathophysiology of spine degeneration. He has published >300 papers, and his works have been cited for > 10,000 times, with H-index > 50 (both based on Web of Science).